240 related articles for article (PubMed ID: 21911653)
21. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.
He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K
J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269
[TBL] [Abstract][Full Text] [Related]
22. The VEGF-C/VEGFR3 signaling pathway contributes to resolving chronic skin inflammation by activating lymphatic vessel function.
Hagura A; Asai J; Maruyama K; Takenaka H; Kinoshita S; Katoh N
J Dermatol Sci; 2014 Feb; 73(2):135-41. PubMed ID: 24252749
[TBL] [Abstract][Full Text] [Related]
23. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
[TBL] [Abstract][Full Text] [Related]
24. Combined blockade of VEGFR-2 and VEGFR-3 inhibits inflammatory lymphangiogenesis in early and middle stages.
Yuen D; Pytowski B; Chen L
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2593-7. PubMed ID: 21273538
[TBL] [Abstract][Full Text] [Related]
25. The Blockade of Vascular Endothelial Growth Factor C Effectively Inhibits Corneal Lymphangiogenesis and Promotes Allograft Survival.
Yan H; Yuan J; Peng R; Wang T; Deng J; Li W; Ling S
J Ocul Pharmacol Ther; 2015 Nov; 31(9):546-54. PubMed ID: 26172526
[TBL] [Abstract][Full Text] [Related]
26. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
[TBL] [Abstract][Full Text] [Related]
27. Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.
Cursiefen C; Maruyama K; Jackson DG; Streilein JW; Kruse FE
Cornea; 2006 May; 25(4):443-7. PubMed ID: 16670483
[TBL] [Abstract][Full Text] [Related]
28. Corneal lymphangiogenesis facilitates ocular surface inflammation and cell trafficking in dry eye disease.
Ji YW; Lee JL; Kang HG; Gu N; Byun H; Yeo A; Noh H; Kim S; Choi EY; Song JS; Lee HK
Ocul Surf; 2018 Jul; 16(3):306-313. PubMed ID: 29601983
[TBL] [Abstract][Full Text] [Related]
29. Anti-VEGF-A therapy reduces lymphatic vessel density and expression of VEGFR-3 in an orthotopic breast tumor model.
Whitehurst B; Flister MJ; Bagaitkar J; Volk L; Bivens CM; Pickett B; Castro-Rivera E; Brekken RA; Gerard RD; Ran S
Int J Cancer; 2007 Nov; 121(10):2181-91. PubMed ID: 17597103
[TBL] [Abstract][Full Text] [Related]
30. Lymphangiogenesis in chronic inflammation in the testis.
Hirai S; Naito M; Terayama H; Qu N; Kuerban M; Musha M; Itoh M
Andrology; 2013 Jan; 1(1):147-54. PubMed ID: 23258644
[TBL] [Abstract][Full Text] [Related]
31. Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis.
Hajrasouliha AR; Funaki T; Sadrai Z; Hattori T; Chauhan SK; Dana R
Invest Ophthalmol Vis Sci; 2012 Mar; 53(3):1244-50. PubMed ID: 22281820
[TBL] [Abstract][Full Text] [Related]
32. Suppression of lymphangiogenesis in human lymphatic endothelial cells by simultaneously blocking VEGF-C and VEGF-D/VEGFR-3 with norcantharidin.
Liu ZY; Qiu HO; Yuan XJ; Ni YY; Sun JJ; Jing W; Fan YZ
Int J Oncol; 2012 Nov; 41(5):1762-72. PubMed ID: 22922710
[TBL] [Abstract][Full Text] [Related]
33. Role of CD11b+ macrophages in intraperitoneal lipopolysaccharide-induced aberrant lymphangiogenesis and lymphatic function in the diaphragm.
Kim KE; Koh YJ; Jeon BH; Jang C; Han J; Kataru RP; Schwendener RA; Kim JM; Koh GY
Am J Pathol; 2009 Oct; 175(4):1733-45. PubMed ID: 19762711
[TBL] [Abstract][Full Text] [Related]
34. Hyperplasia, de novo lymphangiogenesis, and lymphatic regression in mice with tissue-specific, inducible overexpression of murine VEGF-D.
Lammoglia GM; Van Zandt CE; Galvan DX; Orozco JL; Dellinger MT; Rutkowski JM
Am J Physiol Heart Circ Physiol; 2016 Aug; 311(2):H384-94. PubMed ID: 27342876
[TBL] [Abstract][Full Text] [Related]
35. Corneal lymphangiogenesis in dry eye disease is regulated by substance P/neurokinin-1 receptor system through controlling expression of vascular endothelial growth factor receptor 3.
Lee SJ; Im ST; Wu J; Cho CS; Jo DH; Chen Y; Dana R; Kim JH; Lee SM
Ocul Surf; 2021 Oct; 22():72-79. PubMed ID: 34311077
[TBL] [Abstract][Full Text] [Related]
36. Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.
Syväranta S; Helske S; Lappalainen J; Kupari M; Kovanen PT
Atherosclerosis; 2012 Apr; 221(2):366-74. PubMed ID: 22281299
[TBL] [Abstract][Full Text] [Related]
37. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
38. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
[TBL] [Abstract][Full Text] [Related]
39. Regulation of T-cell chemotaxis by programmed death-ligand 1 (PD-L1) in dry eye-associated corneal inflammation.
El Annan J; Goyal S; Zhang Q; Freeman GJ; Sharpe AH; Dana R
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3418-23. PubMed ID: 20019373
[TBL] [Abstract][Full Text] [Related]
40. The maintenance of lymphatic vessels in the cornea is dependent on the presence of macrophages.
Maruyama K; Nakazawa T; Cursiefen C; Maruyama Y; Van Rooijen N; D'Amore PA; Kinoshita S
Invest Ophthalmol Vis Sci; 2012 May; 53(6):3145-53. PubMed ID: 22511631
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
